STML News and Press, Stemline Therapeutics Inc. From 05/04/20

NEW YORK, NY / ACCESSWIRE / May 4, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the pr...

Gainers:  Stemline Therapeutics (NASDAQ: STML ) +154% . More news on: Stemline Therapeutics, Inc., MicroVision, Inc., Contango Oil & Gas Company, Stocks on the move, , Read more ...

NEW YORK , May 4, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Stemline Therapeutics, Inc. (NASDAQ: STML) to Menarini Group is fair to Stemline shareholders. On behalf of Stemline shareholders, Halper Sadeh LLP may seek inc...

Stemline Therapeutics (NASDAQ: STML ) +151%  on Menarini bid . More news on: Stemline Therapeutics, Inc., Applied DNA Sciences, Inc., KLX Energy Services Holdings, Inc., Stocks on the move, , Read more ...

Privately held Menarini Group has agreed to acquire Stemline Therapeutics (NASDAQ: STML ) for $12.50 per share, consisting of $11.50 in cash plus one contingent value right (CVR) that will pay $1.00 in cash upon the completion of the first sale of Elzonris (tagraxofusp) in any EU5 country ...

Acquisition of Stemline establishes Menarini’s presence in the U.S. biopharmaceutical oncology market  Menarini will support further development of Stemline’s ELZONRIS ® and enable global expansion by leveraging its commercial infrastructure in Europe and ot...

The following slide deck was published by Stemline Therapeutics, Inc. in conjunction with this Read more ...

AcelRx Pharmaceuticals Reports Q4 Results, to Acquire Tetraphase Pharmaceuticals AcelRx ( ACRX ) reported its fourth quarter and full-year results while also announcing its plan to acquire Tetraphase Pharmaceuticals (TTPH). The company ended the year with $66.1 million in cash, cash equiva...

Image source: The Motley Fool. Stemline Therapeutics Inc   (NASDAQ: STML) Q4 2019 Earnings Call Mar 16, 2020 , 8:00 a.m. ET Operator Continue reading

Stemline Therapeutics, Inc. (STML) Q4 2019 Results Earnings Conference Call March 16, 2020, 08:00 AM ET Company Participants Kenneth Hoberman - COO Ivan Bergstein - Founder, President, CEO & Chairman David Gionco - Senior VP of Finance & CAO Robert Francomano - Chief Co...